Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients

Matthew T. Hueman, Zia A. Dehqanzada, Thomas E. Novak, Jennifer M. Gurney, Michael M. Woll, Gayle B. Ryan, Catherine E. Storrer, Christine Fisher, David G. McLeod, Constantine G. Ioannides, Sathibalan Ponniah, George E. Peoples

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences